Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Receivables (2020 - 2025)

Definitive Healthcare (DH) has disclosed Receivables for 6 consecutive years, with $54.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables fell 3.65% year-over-year to $54.0 million, compared with a TTM value of $54.0 million through Dec 2025, down 3.65%, and an annual FY2025 reading of $54.0 million, changed 0.13% over the prior year.
  • Receivables was $54.0 million for Q4 2025 at Definitive Healthcare, up from $34.8 million in the prior quarter.
  • Across five years, Receivables topped out at $59.4 million in Q1 2024 and bottomed at $1.0 million in Q4 2021.
  • Average Receivables over 5 years is $36.4 million, with a median of $39.6 million recorded in 2022.
  • The sharpest move saw Receivables crashed 96.9% in 2021, then soared 2396.62% in 2024.
  • Year by year, Receivables stood at $1.0 million in 2021, then surged by 63.2% to $1.7 million in 2022, then soared by 33.61% to $2.2 million in 2023, then skyrocketed by 2396.62% to $56.1 million in 2024, then decreased by 3.65% to $54.0 million in 2025.
  • Business Quant data shows Receivables for DH at $54.0 million in Q4 2025, $34.8 million in Q3 2025, and $39.7 million in Q2 2025.